PRAX 090
Alternative Names: PRAX-090Latest Information Update: 23 Jun 2022
At a glance
- Originator Praxis Precision Medicines
- Class Antiepileptic drugs; Antisense oligonucleotides
- Mechanism of Action RNA interference; SYNGAP1 protein expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Epilepsy